Log on / register
Feedback | Support | My details
Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.
Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER
Cost Eff Resour Alloc 2008, 6:4
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis
Kulasingam SL, Rajan R, St Pierre Y, Atwood CV, Myers ER, Franco EL
BMC Medicine 2009, 7:69 (9 November 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]
2.


Research article
A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females
Anonychuk AM, Bauch CT, Merid MF, Van Kriekinge G, Demarteau N
BMC Public Health 2009, 9:401 (31 October 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.